循环肿瘤细胞预测幼儿非典型畸胎样横纹肌样瘤进展的潜在临床价值
本研究纳入6例3岁以下经综合治疗后维持治疗的非典型畸胎样横纹肌样瘤(ATRT)患儿,比较脑脊液与外周血中循环肿瘤细胞(CTC)及肿瘤衍生循环杂交细胞(CHC)检测的可行性及其对肿瘤进展的预测价值。结果显示脑脊液中CTC+CHC总和诊断效能最高(AUC=0.771,p=0.001,准确率73.5%),外周血CTC+CHC与进展结局一致性显著(Kappa=0.406,p=0.024)。
要点
- 脑脊液CTC+CHC总和以2.5为截断值预测ATRT进展,AUC=0.771,准确率73.5%。
- 脑脊液细胞学假阴性率37.5%,高于MRI的8.3%。
- 外周血CTC单独诊断效能不显著,CTC+CHC与进展一致性Kappa=0.406。
核心结论
- 脑脊液和外周血均可检测到经综合治疗后幼儿ATRT患者的CTC,CTC对监测ATRT进展有可观临床预测价值。
研究设计与样本
- 纳入2023年7月至2024年6月在本机构经综合治疗后维持治疗的3岁以下ATRT患儿6例,收集34份血样和34份脑脊液样本。
- 基于CTC和肿瘤衍生循环杂交细胞(CHC)两种形态分别计数脑脊液和外周血CTC,用ROC曲线AUC确定预测肿瘤进展的阈值,用Kappa系数评估MRI、脑脊液细胞学与CTC以进展(PD)为参考的一致性。
主要发现
- 以PD为参考,脑脊液细胞学假阴性率37.5%,高于MRI的8.3%。
- 脑脊液中CTC+CHC总和诊断效能最高(AUC=0.771,p=0.001,准确率73.5%),截断值2.5。
- 脑脊液所有CTC与PD结局一致性有统计学意义。
- 外周血所有CTC诊断效能不显著;外周血CTC+CHC与PD结局一致性有统计学意义(Kappa=0.406,p=0.024),阴性预测截断值65(AUC=0.397,p=0.371,准确率76.5%)。
关键数值与推荐
- 脑脊液CTC+CHC总和预测ATRT进展的截断值为2.5(AUC=0.771,p=0.001,准确率73.5%)。
- 外周血CTC+CHC阴性预测截断值为65(AUC=0.397,p=0.371,准确率76.5%)。
- 脑脊液细胞学假阴性率37.5%,MRI假阴性率8.3%。
- 外周血CTC+CHC与PD结局一致性Kappa=0.406,p=0.024。
临床怎么用
- 对经综合治疗的幼儿ATRT患者,可同时检测脑脊液和外周血CTC辅助监测肿瘤进展。
- 脑脊液CTC+CHC总和≥2.5提示进展风险,需结合MRI和脑脊液细胞学综合判断。
- 外周血CTC单独诊断效能不显著,不宜单独用于进展判断。
局限性
- 样本量小,仅6例患儿、34份血样和34份脑脊液样本。
- 研究为单中心回顾性设计,CTC检测方法及阈值需外部验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Atypical teratoid rhabdoid tumor (ATRT) is a rare pediatric brain tumor characterized by an extremely poor prognosis despite receiving comprehensive treatments. Circulating tumor cells (CTCs) detection has high clinical value in the prediction of the progression of malignant solid tumors and the evaluation of treatment effects. However, very few studies have focused on CTCs in pediatric CNS embryonal tumors especially ATRT. This study aims to evaluate and compare the feasibility of detecting CTCs in young children with ATRT, and to analyze the clinical value of CTCs count in monitoring ATRT tumor progression. METHODS: Young children under 3 years old who were diagnosed with ATRT and performed maintenance treatment from July 2023 to June 2024 after comprehensive therapy in our institution were enrolled. CTCs count both in cerebrospinal fluid (CSF) and peripheral blood were separately calculated based on two morphological types: CTC and tumor-derived circulating hybrid cells (CHC). Area under the receiver operating characteristic (ROC) curves (AUC) were used to determine the threshold of CTCs in predicting tumor progression. Kappa coefficients were applied to assess consistency between MRI scans, CSF cytology and CTCs by using progressive disease (PD) outcomes as the reference. RESULTS: CTCs count in 34 blood samples and 34 CSF samples, as well as the results of CSF cytology examination and MRI scans in simultaneous period, were collected from six pediatric patients. When the progressive disease (PD) outcomes were used as a reference, CSF cytology test had a higher false negative rate compared with MRI scans (37.5% vs. 8.3%). In CSF, the sum of CTC + CHC had the highest significant diagnostic efficacy (AUC = 0.771, p = 0.001, Accuracy = 73.5%) with a cut-off value of 2.5. All of CSF-CTCs had statistically significant consistency with PD outcomes. In peripheral blood, all of CTCs had insignificant diagnostic efficacy. However, the sum of CTC + CHC had statistically significant consistency with PD outcomes (Kappa value = 0.406, p = 0.024), with a negative prediction cut-off value of 65 (AUC = 0.397, p = 0.371, Accuracy = 76.5%). CONCLUSION: CTCs in CSF and peripheral blood can both be detected in young-age ATRT patients after receiving comprehensive treatment. CTCs have considerable clinical predictive value in monitoring the progression of ATRT.
引用
- Zhang W, Cao K, Zhang X, et al. Potential clinical value of circulating tumor cells in predicting progression for atypical teratoid rhabdoid tumor in young children. J Neurooncol. 2025. PMID: 41148473. doi:10.1007/s11060-025-05293-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。